[go: up one dir, main page]

AU3988099A - Combination therapy for treating hypercholesterolemia - Google Patents

Combination therapy for treating hypercholesterolemia

Info

Publication number
AU3988099A
AU3988099A AU39880/99A AU3988099A AU3988099A AU 3988099 A AU3988099 A AU 3988099A AU 39880/99 A AU39880/99 A AU 39880/99A AU 3988099 A AU3988099 A AU 3988099A AU 3988099 A AU3988099 A AU 3988099A
Authority
AU
Australia
Prior art keywords
combination therapy
treating hypercholesterolemia
hypercholesterolemia
treating
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39880/99A
Inventor
Pradeep K. Dhal
Stephen Randall Holmes-Farley
Chad Cori Huval
John S Petersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geltex Pharmaceuticals Inc
Original Assignee
Geltex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharmaceuticals Inc filed Critical Geltex Pharmaceuticals Inc
Publication of AU3988099A publication Critical patent/AU3988099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39880/99A 1999-05-13 1999-05-13 Combination therapy for treating hypercholesterolemia Abandoned AU3988099A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/010568 WO2000069445A1 (en) 1999-05-13 1999-05-13 Combination therapy for treating hypercholesterolemia

Publications (1)

Publication Number Publication Date
AU3988099A true AU3988099A (en) 2000-12-05

Family

ID=22272752

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39880/99A Abandoned AU3988099A (en) 1999-05-13 1999-05-13 Combination therapy for treating hypercholesterolemia

Country Status (2)

Country Link
AU (1) AU3988099A (en)
WO (1) WO2000069445A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
ATE331512T1 (en) 2001-01-26 2006-07-15 Schering Corp USE OF AZETIDINONE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF SITOSTEROLHEMIA
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
MEP27808A (en) 2001-01-26 2010-10-10 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
GB2373438A (en) * 2001-02-10 2002-09-25 Reckitt & Colmann Prod Ltd Cholesterol lowering compositions
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
JP2005504091A (en) 2001-09-21 2005-02-10 シェーリング　コーポレイション Treatment of xanthomas with azetidinone as a sterol absorption inhibitor
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
EP1485104A1 (en) * 2002-03-18 2004-12-15 Pharmacia Corporation Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
CA2517571C (en) 2003-03-07 2011-07-05 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1606287B1 (en) 2003-03-07 2013-10-02 Merck Sharp & Dohme Corp. Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
MXPA05009501A (en) 2003-03-07 2005-10-18 Schering Corp Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholeterolemia.
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
CN103012789B (en) * 2011-09-23 2015-02-25 北大方正集团有限公司 Preparation method of niacin sevelamer
WO2021150958A1 (en) * 2020-01-24 2021-07-29 Schelling D Christopher Treatment methods using a combination of pantethine and a vanin agonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6203785B1 (en) * 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents

Also Published As

Publication number Publication date
WO2000069445A1 (en) 2000-11-23
WO2000069445A8 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
AU6777300A (en) Treatment apparatus for wounds
AU7842500A (en) System for orthopedic treatment
AU1050401A (en) Device for cardiac therapy
AU5089400A (en) Arthritis treatment
AU3891299A (en) Combination therapy for treatment of depression
EP1176964B8 (en) Uses of et743 for treating cancer
AU2002210462A1 (en) Transdermal therapeutic system for treating restless-legs-syndrome
AU5547000A (en) Novel treatment
AU3988099A (en) Combination therapy for treating hypercholesterolemia
AU773240C (en) Medicament for treating hypertension
GB9907243D0 (en) Therapy
AU2042301A (en) 1-aminoalkyl-1H-indoles for treating glaucoma
AU2451500A (en) Therapeutic agents
AU2266801A (en) Combination therapy for treating neurodegenerative disease
AUPQ232599A0 (en) Drug for treating fractures
AU4556800A (en) Novel treatment
AU1979499A (en) Apparatus for therapeutic electromagnetic treatment
AU5973600A (en) Therapeutic agents
AU1449501A (en) Iontophoretic treatment system
AU1972200A (en) Treatment for fabrics
AU3990399A (en) Combination therapy for treating hypercholesterolemia
AU1036801A (en) Agent for treating cephalic pain
AU6150200A (en) Therapeutic agents
AU4598100A (en) Treating cancer
AU3798500A (en) Verotoxin treatment of lymphomas

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase